Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shusuke Akamatsu

Showing results (111-120 of 216) with videos related to

Pageof 22
Sort By:
Cancer Medicine|December 20, 2022
Ten-year outcomes of whole-pelvic intensity-modulated radiation therapy for prostate cancer with regional lymph node metastasisKiyonao Nakamura, Yoshiki Norihisa, Itaru Ikeda, et al.
Hinyokika Kiyo. Acta Urologica Japonica|May 25, 2022
[Diagnostic Accuracy of Transperineal MRI-Ultrasound Fusion Biopsy at the Introduction Period]Yuto Hattori, Jin Kono, Takayuki Yoshino, et al.
Nature Genetics|August 3, 2010
Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese populationRyo Takata, Shusuke Akamatsu, Michiaki Kubo, et al.
Clinical Genitourinary Cancer|July 17, 2019
Efficacy and Safety of Carboplatin Plus Paclitaxel as the First-, Second-, and Third-line Chemotherapy in Men With Castration-resistant Prostate CancerMaki Fujiwara, Shusuke Akamatsu, Takayuki Sumiyoshi, et al.
JCO Precision Oncology|January 6, 2025
Clinical Utility of Serial Circulating Tumor DNA Analysis as a Minimally Invasive Biomarker in Advanced Urothelial CancerToru Sakatani, Takayuki Sumiyoshi, Yuki Kita, et al.
Urology Case Reports|May 12, 2017
A 45,X/46,XY Male with Orchidopexy Diagnosed with Mixed Germ Cell Tumor After 21-year Follow-upMasashi Kubota, Naoki Terada, Katsuhiro Ito, et al.
Clinical Genitourinary Cancer|June 10, 2023
Pretreatment Lymphocyte to C-Reactive Protein Ratio: An Independent Predictor of Overall Survival in Metastatic Hormone-Naïve Prostate Cancer PatientsTakeshi Sasaki, Toshifumi Takahashi, Sho Sekito, et al.
Frontiers in Oncology|September 19, 2025
Case Report: Genomic insights into prostate adenocarcinoma transdifferentiation to carcinosarcoma due to lineage plasticityTomohiro Fukui, Arinobu Fukunaga, Yuki Teramoto, et al.
Clinical Genitourinary Cancer|October 5, 2015
Effective and Safe Administration of Low-Dose Estramustine Phosphate for Castration-Resistant Prostate CancerTakahiro Inoue, Keiji Ogura, Mutushi Kawakita, et al.
Scientific Reports|October 10, 2025
Efficacy and safety of combination immunotherapy for treating advanced non-clear cell renal cell carcinoma: A multicenter retrospective study in JapanKoji Iinuma, Yuta Sano, Kohei Nishikawa, et al.
Pageof 22

Showing results (111-120 of 216) with videos related to

Sort By:
Pageof 22
Cancer Medicine|December 20, 2022
Ten-year outcomes of whole-pelvic intensity-modulated radiation therapy for prostate cancer with regional lymph node metastasisKiyonao Nakamura, Yoshiki Norihisa, Itaru Ikeda, et al.
Hinyokika Kiyo. Acta Urologica Japonica|May 25, 2022
[Diagnostic Accuracy of Transperineal MRI-Ultrasound Fusion Biopsy at the Introduction Period]Yuto Hattori, Jin Kono, Takayuki Yoshino, et al.
Nature Genetics|August 3, 2010
Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese populationRyo Takata, Shusuke Akamatsu, Michiaki Kubo, et al.
Clinical Genitourinary Cancer|July 17, 2019
Efficacy and Safety of Carboplatin Plus Paclitaxel as the First-, Second-, and Third-line Chemotherapy in Men With Castration-resistant Prostate CancerMaki Fujiwara, Shusuke Akamatsu, Takayuki Sumiyoshi, et al.
JCO Precision Oncology|January 6, 2025
Clinical Utility of Serial Circulating Tumor DNA Analysis as a Minimally Invasive Biomarker in Advanced Urothelial CancerToru Sakatani, Takayuki Sumiyoshi, Yuki Kita, et al.
Urology Case Reports|May 12, 2017
A 45,X/46,XY Male with Orchidopexy Diagnosed with Mixed Germ Cell Tumor After 21-year Follow-upMasashi Kubota, Naoki Terada, Katsuhiro Ito, et al.
Clinical Genitourinary Cancer|June 10, 2023
Pretreatment Lymphocyte to C-Reactive Protein Ratio: An Independent Predictor of Overall Survival in Metastatic Hormone-Naïve Prostate Cancer PatientsTakeshi Sasaki, Toshifumi Takahashi, Sho Sekito, et al.
Frontiers in Oncology|September 19, 2025
Case Report: Genomic insights into prostate adenocarcinoma transdifferentiation to carcinosarcoma due to lineage plasticityTomohiro Fukui, Arinobu Fukunaga, Yuki Teramoto, et al.
Clinical Genitourinary Cancer|October 5, 2015
Effective and Safe Administration of Low-Dose Estramustine Phosphate for Castration-Resistant Prostate CancerTakahiro Inoue, Keiji Ogura, Mutushi Kawakita, et al.
Scientific Reports|October 10, 2025
Efficacy and safety of combination immunotherapy for treating advanced non-clear cell renal cell carcinoma: A multicenter retrospective study in JapanKoji Iinuma, Yuta Sano, Kohei Nishikawa, et al.
Pageof 22